BRYN MAWR TRUST Co Raises Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

BRYN MAWR TRUST Co boosted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPHGet Rating) by 3.3% in the fourth quarter, HoldingsChannel reports. The fund owned 32,469 shares of the company’s stock after acquiring an additional 1,024 shares during the period. BRYN MAWR TRUST Co’s holdings in U.S. Physical Therapy were worth $3,103,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Qube Research & Technologies Ltd purchased a new position in U.S. Physical Therapy during the 4th quarter valued at about $676,000. Citigroup Inc. lifted its position in U.S. Physical Therapy by 35.6% during the 4th quarter. Citigroup Inc. now owns 11,343 shares of the company’s stock valued at $1,084,000 after acquiring an additional 2,978 shares during the period. TD Asset Management Inc. increased its stake in U.S. Physical Therapy by 100.0% during the 4th quarter. TD Asset Management Inc. now owns 29,782 shares of the company’s stock valued at $2,846,000 after purchasing an additional 14,891 shares in the last quarter. Teacher Retirement System of Texas increased its stake in U.S. Physical Therapy by 20.8% during the 4th quarter. Teacher Retirement System of Texas now owns 2,516 shares of the company’s stock valued at $240,000 after purchasing an additional 434 shares in the last quarter. Finally, Aviva PLC increased its stake in U.S. Physical Therapy by 81.6% during the 4th quarter. Aviva PLC now owns 26,551 shares of the company’s stock valued at $2,537,000 after purchasing an additional 11,929 shares in the last quarter. 99.13% of the stock is owned by institutional investors.

Shares of USPH stock traded up $3.82 during trading hours on Friday, reaching $104.32. The company had a trading volume of 67,244 shares, compared to its average volume of 77,059. The business has a fifty day moving average price of $100.46 and a 200-day moving average price of $97.68. U.S. Physical Therapy, Inc. has a one year low of $84.43 and a one year high of $123.38. The firm has a market cap of $1.36 billion, a PE ratio of 36.22 and a beta of 1.23. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.14 and a current ratio of 1.08.

U.S. Physical Therapy (NYSE:USPHGet Rating) last announced its quarterly earnings results on Thursday, May 5th. The company reported $0.65 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.02. U.S. Physical Therapy had a net margin of 7.69% and a return on equity of 14.77%. The firm had revenue of $131.70 million during the quarter, compared to analyst estimates of $128.57 million. During the same period in the previous year, the business posted $0.64 earnings per share. The business’s revenue for the quarter was up 17.2% on a year-over-year basis. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 3.33 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 14th. Stockholders of record on Monday, May 16th will be paid a $0.41 dividend. The ex-dividend date is Friday, May 13th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.57%. U.S. Physical Therapy’s dividend payout ratio is presently 56.94%.

A number of analysts have weighed in on the stock. StockNews.com assumed coverage on shares of U.S. Physical Therapy in a research note on Thursday, March 31st. They set a “hold” rating for the company. Barrington Research reduced their price objective on shares of U.S. Physical Therapy from $144.00 to $123.00 in a research note on Friday, February 25th. Finally, Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Saturday, May 7th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $115.00.

In related news, insider Eric Joseph Williams sold 500 shares of the firm’s stock in a transaction that occurred on Monday, March 14th. The shares were sold at an average price of $93.15, for a total value of $46,575.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Harry S. Chapman sold 1,280 shares of the firm’s stock in a transaction that occurred on Thursday, March 17th. The stock was sold at an average price of $96.02, for a total transaction of $122,905.60. The disclosure for this sale can be found here. Insiders sold 7,218 shares of company stock valued at $676,259 over the last quarter. Company insiders own 1.90% of the company’s stock.

About U.S. Physical Therapy (Get Rating)

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPHGet Rating).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.